These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4346201)

  • 1. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 2. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 3. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kidney repercussions of bile duct contrast media administration].
    Billis A; Dimopoulos C; Giamarellou H; Zoubouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daikos G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):447-50. PubMed ID: 4804417
    [No Abstract]   [Full Text] [Related]  

  • 5. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical trial of oral cholecystographic agents: telepaque, sodium oragrafin and calcium oragrafin.
    Tishler JM; Gold R
    J Can Assoc Radiol; 1969 Jun; 20(2):102-5. PubMed ID: 5793435
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choleretic action of sodium tyropanoate (bilopaque sodium) in the dog: preliminary observation.
    Nelson JA; Straubus AE; Amberg JR
    Invest Radiol; 1974; 9(6):438-43. PubMed ID: 4430583
    [No Abstract]   [Full Text] [Related]  

  • 9. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of ethambutol-induced hyperuricemia.
    Postlethwaite AE; Kelley WN
    Arthritis Rheum; 1972; 15(4):403-9. PubMed ID: 5046470
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque.
    Smith HJ; Corbett DB; Loeb PM; Peterson WL
    Invest Radiol; 1982; 17(6):629-33. PubMed ID: 6759457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of fractional excretion of uric acid in the diagnosis of acute kidney injury due to decreased kidney perfusion.
    Kosmadakis G; Viskaduraki M; Michail S
    Am J Kidney Dis; 2009 Dec; 54(6):1186-7. PubMed ID: 19932879
    [No Abstract]   [Full Text] [Related]  

  • 14. Uricosuria and x-ray contrast agents.
    Kelley WN
    N Engl J Med; 1971 Apr; 284(17):975-6. PubMed ID: 5573284
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine uric acid and urine creatine ratio in acute renal failure.
    Tungsanga K; Boonwichit D; Lekhakula A; Sitprija V
    Arch Intern Med; 1984 May; 144(5):934-7. PubMed ID: 6712409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of locetamic acid, lopanoic acid and tyropanoate sodium.
    Marshall TR
    J Indiana State Med Assoc; 1976 Oct; 69(10):742-3. PubMed ID: 135811
    [No Abstract]   [Full Text] [Related]  

  • 17. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic effects of nicotinic acid on human purine metabolism.
    Gershon SL; Fox IH
    J Lab Clin Med; 1974 Aug; 84(2):179-86. PubMed ID: 4367231
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial of oral cholecystography using combinations of contrast agents and two consecutive doses.
    Thoeni RF; Moss AA
    Radiology; 1982 Jul; 144(2):271-5. PubMed ID: 7045975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.